Call for evidence on skin sensitisers in consumer mixtures
The competent authorities of Ireland, Germany and France have issued a call for evidence (CfE) for all sectors to provide information on the presence of skin sensitising substances in mixtures with consumer uses, including information on known safe uses.
In addition, epidemiological data on allergic contact dermatitis and information on health costs are requested. This CfE allows stakeholders and contact points within relevant sectors to identify themselves for possible subsequent consultations. The information gathered will provide valuable input to assess any potential need for regulatory actions on skin sensitisers in consumer mixtures in order to prevent skin sensitisation and allergic contact dermatitis in the general population.
This Call for Evidence is issued to assess (i) whether there are risks that are adequately controlled under specific conditions, and (ii) what impact additional regulatory risk management would have on society. The scope of the investigation comprises substances fulfilling the criteria for classification as skin sensitisers as defined by the CLP Regulation (Regulation (EC) 1272/2008) in mixtures marketed or available for consumers in the EU/EEA. Uses of substances in cosmetic products, as defined by Directive 76/768/EEC, are outside the scope of the investigation (according to the REACH Regulation, Article 67).
For more information, the consultation is published on the ECHA website at:
The deadline for comments closes on 30th September 2022
Please contact the Chemicals Helpdesk on email@example.com if you require any clarification on this call for evidence.
ECHA Public Consultations
All current ECHA consultations can be viewed on their website at https://www.echa.europa.eu/web/guest/consultations/current
The Authorisation Process
The authorisation procedure aims to assure that the risks from Substances of Very High Concern (SVHCs) are properly controlled and that these substances are progressively replaced by suitable alternatives while ensuring the good functioning of the EU internal market. There are three steps in this process whereby ECHA consults with the public, identification of substances to be included in the Candidate List, recommendation for inclusion of substances from the Candidate List onto the Authorisation List (Annex XIV) and applications for the use of substances included on the Authorisation List (Annex XIV). Any on-going consultations in this area can be viewed on ECHA’s website at the link indicated above.
Restrictions under Consideration
Restrictions on the manufacture, placing on the market and use of certain dangerous substances, preparations and articles can have serious trade implications. Restrictions can also have implications for the end user or consumer, as certain products may no longer be on the market for a particular use. ECHA holds public consultations on all restrictions proposals, and stakeholders can submit comments during these consultations.
The Chemicals Helpdesk of the HSA aims to ensure that all stakeholders are consulted as early as possible in the process so that they are given the opportunity to comment on the proposed restrictions and to make any necessary changes to their processes. If you want to be kept informed about upcoming restrictions proposals under REACH you should subscribe to the HSA’s Chemicals E- bulletin. Public consultations on all restrictions are facilitated through the ECHA & EU Consultations website.
ECHA also hosts a Registry of Intentions on its website. This registry allows stakeholders to keep up to date with information on Member State intentions to submit a restriction dossier in the future.
Substances for Harmonised Classification & Labelling
The classification and labelling of certain hazardous chemicals must be harmonised to ensure adequate risk management throughout the European Union. Harmonised classifications and labelling are mandatory for the suppliers of respective substances so that users are better informed about their potential hazardous effects and how best to make use of them safely. The harmonised classification and labelling process includes a period of public consultation that lasts 45 days. Please see ECHA's current consultations.
To ensure that the best use has been made of existing information, particularly information on existing vertebrate tests, ECHA publishes all test proposals involving vertebrate animals, for endpoints specified in Annexes IX and X under REACH, on this webpage before the testing is carried out. After a testing proposal has been published, third parties have 45 days to submit "scientifically valid information and studies that address the relevant substance and hazard endpoint, relating to the testing proposal". Please see ECHA's current consultations.
Occupational Exposure Limits
ECHA and its Committee for Risk Assessment (RAC) have been supporting the European Commission's Directorate-General for Employment, Social Affairs and Inclusion (DG EMPL) by providing scientific opinions on OELs since 2019. RAC provides opinions on occupational exposure limits under the Carcinogens and Mutagens Directive (2004/37/EC) and the Chemical Agents Directive (98/24/EC) on worker protection from risks related to exposure to substances found in the workplace.
The table at this link provides up-to-date information on the activities planned, ongoing or completed by ECHA in relation to its work on occupational exposure limits.
EU Commission Public Consultations
The EU Commission is welcoming feedback on their fitness check roadmap for the assessment of EU chemicals legislation in regulating endocrine disrupting substances. Endocrine disruptors are regulated specifically in some legislation, and more generally in others. The aim of the fitness check is to ensure that these substances are sufficiently regulated to ensure a high level of protection for human health and the environment.
For more information or to provide feedback, please see the EU Commission website.
Return to Chemicals Homepage